TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group.

Winnie Yeo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.